Literature DB >> 26526893

Influence of antibiotic pressure on bacterial bioluminescence, with emphasis on Staphylococcus aureus.

Seyedmojtaba Daghighi1, Jelmer Sjollema1, Akshay Harapanahalli1, Rene J B Dijkstra1, Henny C van der Mei2, Henk J Busscher1.   

Abstract

Bioluminescence imaging is used for longitudinal evaluation of bacteria in live animals. Clear relations exist between bacterial numbers and their bioluminescence. However, bioluminescence images of Staphylococcus aureus Xen29, S. aureus Xen36 and Escherichia coli Xen14 grown on tryptone soy agar in Etests demonstrated increased bioluminescence at sub-MICs of different antibiotics. This study aimed to further evaluate the influence of antibiotic pressure on bioluminescence in S. aureus Xen29. Bioluminescence of S. aureus Xen29, grown planktonically in tryptone soy broth, was quantified in the absence and presence of different concentrations of vancomycin, ciprofloxacin, erythromycin or chloramphenicol and was related to expression of the luxA gene under antibiotic pressure measured using real-time PCR. In the absence of antibiotics, staphylococcal bioluminescence increased over time until a maximum after ca. 6h of growth, and subsequently decreased to the detection threshold after 24h of growth owing to reduced bacterial metabolic activity. Up to MICs of the antibiotics, bioluminescence increased according to a similar pattern up to 6h of growth, but after 24h bioluminescence was higher than in the absence of antibiotics. Contrary to expectations, bioluminescence per organism (CFU) after different growth periods in the absence and at MICs of different antibiotics decreased with increasing expression of luxA. Summarising, antibiotic pressure impacts the relation between CFU and bioluminescence. Under antibiotic pressure, bioluminescence is not controlled by luxA expression but by co-factors impacting the bacterial metabolic activity. This conclusion is of utmost importance when evaluating antibiotic efficacy in live animals using bioluminescent bacterial strains.
Copyright © 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Keywords:  Chloramphenicol; Ciprofloxacin; Erythromycin; Vancomycin; luxA gene

Mesh:

Substances:

Year:  2015        PMID: 26526893     DOI: 10.1016/j.ijantimicag.2015.09.007

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  4 in total

1.  Influence of Antibiotic Pressure on Five Plasmid-based Bioluminescent Gram-negative Bacterial Strains.

Authors:  Xiwen Wang; Hang Chi; Qianxue Li; Wenliang Li; Jiakuan Li; Bo Li; Weicun Gao; Da Zhang; Yu Sun; Le Yi; Han Qu; Yutian Wang; Zhiping Li; Zhiping Xia
Journal:  Mol Imaging Biol       Date:  2018-02       Impact factor: 3.488

2.  Influence of sub-inhibitory concentrations of antimicrobials on micrococcal nuclease and biofilm formation in Staphylococcus aureus.

Authors:  Colin W K Rosman; Henny C van der Mei; Jelmer Sjollema
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

3.  Sustained activity of novel THIOMAB antibody-antibiotic conjugate against Staphylococcus aureus in a mouse model: Longitudinal pharmacodynamic assessment by bioluminescence imaging.

Authors:  Chenguang Zhou; Hao Cai; Amos Baruch; Nicholas Lewin-Koh; Meng Yang; Fengxun Guo; Deming Xu; Rong Deng; Wouter Hazenbos; Amrita V Kamath
Journal:  PLoS One       Date:  2019-10-29       Impact factor: 3.240

4.  Micrococcal Nuclease stimulates Staphylococcus aureus Biofilm Formation in a Murine Implant Infection Model.

Authors:  Abigail M Forson; Colin W K Rosman; Theo G van Kooten; Henny C van der Mei; Jelmer Sjollema
Journal:  Front Cell Infect Microbiol       Date:  2022-01-17       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.